Conditions:  Pancreatic Acinar Cell Carcinoma;  Pancreatic Adenosquamous Carcinoma;  Pancreatic Squamous Cell Carcinoma;  Resectable Pancreatic Acinar Cell Carcinoma;  Resectable Pancreatic Adenocarcinoma;  Resectable Pancreatic Adenosquamous Carcinoma;  Resectable Pancreatic Carcinoma
Interventions:  Drug: Olaparib;  Drug: Placebo Administration
Sponsor:  National Cancer Institute (NCI)
**RECRUITING NOW**
Interventions:  Drug: Olaparib;  Drug: Placebo Administration
Sponsor:  National Cancer Institute (NCI)
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
